Invention Grant
- Patent Title: Methods for treating cancer and the use of biomarkers as a predictor of clinical sensitivity to therapies
-
Application No.: US16840299Application Date: 2020-04-03
-
Publication No.: US11460471B2Publication Date: 2022-10-04
- Inventor: Ellen Filvaroff , Antonia Lopez-Girona , Gang Lu
- Applicant: CELGENE CORPORATION
- Applicant Address: US NJ Summit
- Assignee: CELGENE CORPORATION
- Current Assignee: CELGENE CORPORATION
- Current Assignee Address: US NJ Summit
- Agency: Jones Day
- Main IPC: A61K31/454
- IPC: A61K31/454 ; A61P35/00 ; C12Q1/68 ; G01N33/574 ; A61K45/06 ; C12Q1/6886 ; A61P35/02
Abstract:
A method of identifying a subject having cancer who is likely to be responsive to a treatment compound, comprising administering the treatment compound to the subject having the cancer; obtaining a sample from the subject; determining the level of a biomarker in the sample from the subject; and diagnosing the subject as being likely to be responsive to the treatment compound if the level of the biomarker in the sample of the subject changes as compared to a reference level of the biomarker; wherein the treatment compound is a compound of Formula I:
Public/Granted literature
Information query
IPC分类:
